ZA882079B - Compositions and methods of effecting contraception - Google Patents

Compositions and methods of effecting contraception

Info

Publication number
ZA882079B
ZA882079B ZA882079A ZA882079A ZA882079B ZA 882079 B ZA882079 B ZA 882079B ZA 882079 A ZA882079 A ZA 882079A ZA 882079 A ZA882079 A ZA 882079A ZA 882079 B ZA882079 B ZA 882079B
Authority
ZA
South Africa
Prior art keywords
compositions
methods
melatonin
effecting contraception
contraception
Prior art date
Application number
ZA882079A
Other languages
English (en)
Inventor
Michael Cohen
Original Assignee
Applied Med Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Med Res filed Critical Applied Med Res
Publication of ZA882079B publication Critical patent/ZA882079B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
ZA882079A 1987-03-23 1988-03-23 Compositions and methods of effecting contraception ZA882079B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/029,229 US4855305A (en) 1987-03-23 1987-03-23 Compositions and methods of effecting contraception utilizing melatonin

Publications (1)

Publication Number Publication Date
ZA882079B true ZA882079B (en) 1988-09-15

Family

ID=21847942

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA882079A ZA882079B (en) 1987-03-23 1988-03-23 Compositions and methods of effecting contraception

Country Status (26)

Country Link
US (1) US4855305A (fr)
EP (1) EP0354921B1 (fr)
JP (2) JP2965160B2 (fr)
KR (1) KR890700349A (fr)
CN (1) CN1041383C (fr)
AT (1) ATE143807T1 (fr)
AU (3) AU628784B2 (fr)
BG (1) BG51075A1 (fr)
BR (1) BR8807426A (fr)
CA (1) CA1322527C (fr)
DD (1) DD269557A5 (fr)
DE (1) DE3855606T2 (fr)
EG (1) EG18583A (fr)
ES (1) ES2009251A6 (fr)
FI (1) FI894423A (fr)
GR (1) GR1002146B (fr)
HU (1) HU208487B (fr)
IL (1) IL85814A (fr)
IN (1) IN166946B (fr)
NZ (1) NZ223989A (fr)
OA (1) OA09134A (fr)
PH (1) PH26709A (fr)
PT (1) PT87053B (fr)
RU (1) RU2114621C1 (fr)
WO (1) WO1988007370A1 (fr)
ZA (1) ZA882079B (fr)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR1001395B (el) * 1987-03-23 1993-10-29 Michael Cohen Συν?έσεις και μέ?οδοι προς πραγματοποίηση αντισύλληψης.
EP0300630A3 (fr) * 1987-07-03 1990-03-28 Schering Agrochemicals Limited Mélatonine pour la régulation de la reproduction des animaux
EP0305194A3 (fr) * 1987-08-28 1990-03-28 Schering Agrochemicals Limited Composition vétérinaire
US4945103A (en) * 1989-01-17 1990-07-31 Michael Cohen Method of treating pre-menstrual syndrome
IN170311B (fr) * 1989-01-17 1992-03-14 Cohen Michael
GR900100024A (el) * 1989-01-17 1991-06-07 Amr Int Μέθοδος θεραπείας του προεμμηνορροϊκού συνδρόμου.
AU644367B2 (en) * 1989-05-17 1993-12-09 Applied Medical Research Ltd Use of melatonin derivatives for effecting contraception
NZ233697A (en) * 1989-05-17 1996-12-20 Applied Med Res Ltd Contraceptive composition comprising a melatonin analogue and a progestogen and/or an estrogen
IT1243193B (it) * 1990-08-10 1994-05-24 Medea Res Srl Composizioni farmaceutiche orali a base di melatonina
EP0641565B1 (fr) * 1990-09-28 2000-03-15 I.F.L.O. S.a.s. di Giorgio e Aldo Laguzzi Médicament contraceptif et régulateur du cycle menstruel, ayant des proprietés oncostatiques
ES2134789T3 (es) * 1991-05-09 1999-10-16 Neurim Pharma 1991 Composiciones que contienen melatonina.
CA2116036A1 (fr) * 1991-10-18 1993-04-29 F. Eugene Yates Dispositif d'administration transdermique de melatonine
US5196435A (en) * 1991-11-21 1993-03-23 Eli Lilly And Company Melatonin derivatives and combinations with antiestrogen compounds for treating mammalian breast carcinoma
ATE141051T1 (de) * 1992-04-07 1996-08-15 Neurim Pharma 1991 Verwendung von melatonin zur herstellung eines arzneimittels zur behandlung der gutartigen prostatahyperplasie
US6403631B1 (en) 1995-11-24 2002-06-11 Equitech Laboratories, Inc. Method and compositions for enhancing pregnancy success in an animal
US5792785A (en) * 1995-11-24 1998-08-11 Equitech Laboratories, Inc. Method for enhancing pregnancy success in an animal
US6028064A (en) * 1996-09-13 2000-02-22 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of progestin products
US6620836B1 (en) * 1997-01-22 2003-09-16 Jay Patrick Antiarrhythmic and tranquilizer composition and treatment
DE19739916C2 (de) * 1997-09-11 2001-09-13 Hesch Rolf Dieter Verwendung einer Kombination aus einem Gestagen und einem Estrogen zur kontinuierlichen Ovulationshemmung und ggf. gleichzeitigen Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen
EP1030669A2 (fr) 1997-11-14 2000-08-30 Akzo Nobel N.V. Regime progestatif-antiprogestatif
US6133453A (en) * 1998-05-15 2000-10-17 Pharm-Eco Laboratories, Inc. Method for making substituted indoles
US7989436B2 (en) 2003-07-23 2011-08-02 Duramed Pharmaceuticals, Inc. Estrogenic compounds and pharmaceutical formulations comprising the same
US6660726B2 (en) * 2000-03-10 2003-12-09 Endeavor Pharmaceuticals Estrogenic compounds, pharmaceutical compositions thereof, and methods of using same
US6855703B1 (en) 2000-03-10 2005-02-15 Endeavor Pharmaceuticals Pharmaceutical compositions of conjugated estrogens and methods of analyzing mixtures containing estrogenic compounds
US7459445B2 (en) * 2000-03-10 2008-12-02 Duramed Pharmaceuticals, Inc. Estrogenic compounds and topical pharmaceutical formulations of the same
US20040176336A1 (en) * 2000-03-21 2004-09-09 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
US20050113351A1 (en) * 2000-03-21 2005-05-26 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
EP1315502B1 (fr) * 2000-08-30 2010-03-17 Unimed Pharmaceuticals, LLC Methode pour traiter la dyserection et augmenter la libido chez l'homme
US6503894B1 (en) 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
US20030139384A1 (en) * 2000-08-30 2003-07-24 Dudley Robert E. Method for treating erectile dysfunction and increasing libido in men
WO2003077900A1 (fr) * 2002-03-14 2003-09-25 Prevention, L.L.C. Mecanisme d'unification et methodes de prevention du cancer et de maladies neurodegeneratives
US6992075B2 (en) * 2003-04-04 2006-01-31 Barr Laboratories, Inc. C(14) estrogenic compounds
CA2521471A1 (fr) * 2003-04-11 2004-10-28 Barr Laboratories, Inc. Procede d'administration d'oestrogenes et de progestatifs
ES2297461T3 (es) 2003-09-09 2008-05-01 Fumapharm Ag Uso de derivados del acido fumarico para tratar la insuficiencia cardiaca y el asma.
EP1755618A1 (fr) * 2004-05-26 2007-02-28 Wyeth a Corporation of the State of Delaware Compositions et methodes pour traiter un trouble dysphorique premenstruel
ES2523796T1 (es) 2004-10-08 2014-12-01 Forward Pharma A/S Composición farmacéutica de liberación controlada que comprende éster de ácido fumárico
SI1937276T1 (sl) 2005-10-12 2013-04-30 Unimed Pharmaceuticals, Llc C/O Abbott Laboratoires 100 Abbott Park Road Izboljšani testosteronski gel in postopek uporabe
EP2068695A2 (fr) * 2006-09-13 2009-06-17 Koninklijke Philips Electronics N.V. Dispositif de régulation automatique d'une dose de mélatonine et/ou de l'administration de mélatonine
US20110112196A1 (en) 2007-02-08 2011-05-12 Matvey E Lukashev Nrf2 screening assays and related methods and compositions
DE102008036825A1 (de) * 2008-08-05 2010-02-11 Aicuris Gmbh & Co. Kg Schwangerschaftsvermeidung durch Gestagene
FR2937862B1 (fr) * 2008-11-03 2010-11-19 Mohammed Ridha Chakroun Kit contraceptif
CN114392228A (zh) * 2014-03-27 2022-04-26 安达卢西亚健康服务部 呈现长期稳定性的褪黑素注射剂的持久制剂
RU2617518C2 (ru) * 2015-07-01 2017-04-25 Общество с ограниченной ответственностью "Научно-внедренческий центр Агроветзащита" Способ регулирования полового поведения и контрацепции самок млекопитающих
RU2616252C2 (ru) * 2015-08-04 2017-04-13 Общество с ограниченной ответственностью "Научно-внедренческий центр Агроветзащита" Способ регулирования полового поведения самцов млекопитающих

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4087444A (en) * 1976-09-08 1978-05-02 Eli Lilly And Company Amides as ovulation inhibitors
DE2967049D1 (en) * 1978-04-11 1984-07-19 Efamol Ltd Pharmaceutical and dietary composition comprising gamma-linolenic acids
US4425339A (en) * 1981-04-09 1984-01-10 Syntex (U.S.A.) Inc. Treatment of menopausal symptoms
US4390531A (en) * 1981-08-10 1983-06-28 Syntex Pharmaceuticals International Ltd. Method of contraception using peak progestogen dosage
US4628051A (en) * 1983-09-26 1986-12-09 Ortho Pharmaceutical Corporation Triphasic oral contraceptive
US4614807A (en) * 1984-10-04 1986-09-30 Eli Lilly And Company 6,7-dihalomelatonins
US4746674A (en) * 1985-08-27 1988-05-24 Cellena (Cell Engineering) Ag Melatonin compositions and uses thereof
EP0214254B1 (fr) * 1985-03-04 1992-06-17 Cellena (Cell Engineering) A.G. Compositions de melatonine et leurs utilisations
US4997845A (en) * 1987-02-02 1991-03-05 Eli Lilly And Company β-alkylmelatonins as ovulation inhibitors

Also Published As

Publication number Publication date
EG18583A (en) 1993-06-30
KR890700349A (ko) 1989-04-24
IL85814A0 (en) 1990-02-09
CA1322527C (fr) 1993-09-28
AU1683088A (en) 1988-11-02
ATE143807T1 (de) 1996-10-15
DE3855606D1 (de) 1996-11-14
WO1988007370A1 (fr) 1988-10-06
HU208487B (en) 1993-11-29
PT87053A (pt) 1989-03-30
RU2114621C1 (ru) 1998-07-10
OA09134A (en) 1991-10-31
GR1002146B (en) 1996-02-19
FI894423A0 (fi) 1989-09-19
JPH02502724A (ja) 1990-08-30
BG51075A1 (en) 1993-02-15
DD269557A5 (de) 1989-07-05
US4855305A (en) 1989-08-08
GR880100177A (el) 1989-01-31
IN166946B (fr) 1990-08-11
EP0354921A1 (fr) 1990-02-21
FI894423A (fi) 1989-09-19
CN88101379A (zh) 1988-10-05
PH26709A (en) 1992-09-15
PT87053B (pt) 1993-09-30
NZ223989A (en) 1991-08-27
IL85814A (en) 1992-05-25
CN1041383C (zh) 1998-12-30
AU5513494A (en) 1994-04-14
EP0354921B1 (fr) 1996-10-09
HUT52954A (en) 1990-09-28
ES2009251A6 (es) 1989-09-16
AU676523B2 (en) 1997-03-13
EP0354921A4 (en) 1991-08-07
JP2965160B2 (ja) 1999-10-18
AU628784B2 (en) 1992-09-24
JPH1171276A (ja) 1999-03-16
BR8807426A (pt) 1990-04-10
DE3855606T2 (de) 1997-02-13
AU8693891A (en) 1991-12-19

Similar Documents

Publication Publication Date Title
EG18583A (en) Compositions and methods of effecting contraception
PL323729A1 (en) Skin sticking plaster and method of administering sole 17-deacetyl norgestimate or together with estrogen
IL92069A0 (en) Contraception system and method
SG55093G (en) Combination dosage form for premenopausal women
ZA8410015B (en) Multistage combination preparation and its use for oral contraception
AR028809A1 (es) Un metodo anticonceptivo y una unidad anticonceptiva oral trifasica
MY121623A (en) Methods of preventing breast cancer.
CA2056364A1 (fr) Compositions et methodes pour la contraception
GR900100369A (en) Contraception compositions and methods
BE894860A (fr) Therapeutique adjuvante par agent progestatif
IT1243978B (it) Farmaco per uso umano, ad azione contraccettiva ed oncostatica preventiva, nei tumori del seno, dell'utero e nel melanoma.
MX9604426A (es) Reduccion de irritacion de la piel durante el surtido por electrotransporte.